Survival after minimally invasive versus open surgery for pancreatic adenocarcinoma

The five-year overall survival rate among patients with pancreatic adenocarcinoma is 9%. Adequate surgical resection, often in combination with preoperative chemoradiotherapy or postoperative chemotherapy, is patient’s only chance to be cured. A retrospective propensity score matched study at the University of Leuven (Belgium) found that among patients with resectable and borderline resectable pancreatic adenocarcinoma, minimally invasive pancreatic surgery was associated with better OS and DFS when compared with open pancreatic surgery.